Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
AT ›
ATACANDHCT
Trademark search for:
ATACANDHCT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-04-19 — Application filed
2005-04-27 — Application filed
2005-07-14 — Preliminary/voluntary amendment - entered
2005-07-14 — Paper received
2005-11-16 — Assigned to examiner
2005-11-17 — Attorney review completed
2005-11-17 — Examiners amendment -written
2005-11-17 — Approved for pub - principal register
2005-11-17 — Examiners amendment e-mailed
2005-11-18 — Assigned to lie
2005-12-07 — Law office publication review completed
2005-12-28 — Notice of publication
2006-01-17 — Published for opposition
2006-04-11 — Noa mailed - sou required from applicant
2006-09-15 — Sou teas extension received
2006-09-15 — Sou extension 1 filed
2006-10-16 — Sou extension 1 granted
2007-04-10 — Sou teas extension received
2007-04-10 — Sou extension 2 filed
2007-04-10 — Sou extension 2 granted
2007-04-13 — Teas statement of use received
2007-04-13 — Use amendment filed
2007-07-16 — Statement of use processing complete
2007-07-17 — Allowed principal register - sou accepted
2007-07-23 — Attorney/dom.rep.revoked and/or appointed
2007-07-23 — Teas revoke/app/change addr of atty/dom rep received
2007-08-27 — Law office registration review completed
2007-08-27 — Assigned to lie
2007-10-02 — Registered-principal register
2013-07-22 — Teas section 8 & 15 received
2013-08-02 — Case assigned to post registration paralegal
2013-08-02 — Registered - sec. 8 (6-yr) accepted & sec. 15 ack.
2013-08-02 — Notice of acceptance of sec. 8 & 15 - e-mailed
2016-10-02 — Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
2018-05-04 — Cancelled sec. 8 (10-yr)/expired section 9
2018-05-04 — Final status recorded
Owner Information
AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE
Correspondent
Wm. Charles Saunders AstraZeneca Pharmaceuticals LP 1800 Concord Pike FOP3-318 Wilmington, DE 19850-5437
Filing Details
Filing Date:
2005-04-19
Status Date:
2018-05-04
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.